Arrowhead battles Ionis over patent dispute tied to RNAi candidate that could rival Tryngolza
Arrowhead Pharmaceuticals has launched legal action against Ionis Pharmaceuticals, aiming to neutralize Ionis’ claim that Arrowhead’s potential rival to Tryngolza breaches a patent. Arrowhead claims that Ionis’ patent is “invalid…